Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
38262087
DOI
10.1016/j.bioorg.2024.107138
PII: S0045-2068(24)00043-9
Knihovny.cz E-resources
- Keywords
- Biological activities, InhA inhibitors, Molecular docking, Molecular dynamics Simulation, Mycobacterium tuberculosis,
- MeSH
- Antitubercular Agents pharmacology chemistry MeSH
- Bacterial Proteins metabolism MeSH
- Quinolines * pharmacology MeSH
- Isatin * pharmacology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Mycobacterium tuberculosis * MeSH
- Oxidoreductases metabolism MeSH
- Acyl Carrier Protein pharmacology MeSH
- Molecular Docking Simulation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antitubercular Agents MeSH
- Bacterial Proteins MeSH
- Quinolines * MeSH
- Isatin * MeSH
- Oxidoreductases MeSH
- Acyl Carrier Protein MeSH
Tuberculosis (TB) is a global issue that poses a significant economic burden as a result of the ongoing emergence of drug-resistant strains. The urgent requirement for the development of novel antitubercular drugs can be addressed by targeting specific enzymes. One such enzyme, Mycobacterium tuberculosis (MTB) enoyl-acyl carrier protein (enoyl-ACP) reductase (InhA), plays a crucial role in the survival of the MTB bacterium. In this research study, a series of hybrid compounds combining quinolone and isatin were synthesized and assessed for their effectiveness against MTB, as well as their ability to inhibit the activity of the InhA enzyme in this bacterium. Among the compounds tested, 7a and 5g exhibited the most potent inhibitory activity against MTB, with minimum inhibitory concentration (MIC) values of 55 and 62.5 µg/mL, respectively. These compounds were further evaluated for their inhibitory effects on InhA and demonstrated significant activity compared to the reference drug Isoniazid (INH), with IC50 values of 0.35 ± 0.01 and 1.56 ± 0.06 µM, respectively. Molecular docking studies investigated the interactions between compounds 7a and 5g and the target enzyme, revealing hydrophobic contacts with important amino acid residues in the active site. To further confirm the stability of the complexes formed by 5g and 7a with the target enzyme, molecular dynamic simulations were employed, which demonstrated that both compounds 7a and 5g undergo minor structural changes and remain nearly stable throughout the simulated process, as assessed through RMSD, RMSF, and Rg values.
Department of Medical Physiology College of Medicine King Khalid University Asir 61421 Saudi Arabia
Institute of Natural Products Chemistry VAST 18 Hoang Quoc Viet Caugiay Hanoi 10000 Viet Nam
Institute of Organic Chemistry and Biochemistry Academy of Sciences Prague Czech Republic
References provided by Crossref.org